Takeshita Shuji | Drug Safety Evaluation Lead Optimizaion Drug Innovation & Approval Divistion Aventis Pharma Ltd.
スポンサーリンク
概要
- TAKESHITA Shujiの詳細を見る
- 同名の論文著者
- Drug Safety Evaluation Lead Optimizaion Drug Innovation & Approval Divistion Aventis Pharma Ltd.の論文著者
関連著者
-
Kawamura Nobuyuki
European Federation of Pharmaceutical Industries and Associations
-
Takeshita Shuji
Drug Safety Evaluation Lead Optimizaion Drug Innovation & Approval Divistion Aventis Pharma Ltd.
-
Kawamura Naohisa
Research Department Saitama Daiichi Pharmaceutical Co. Ltd.
-
Tsutsumi Shunsuke
Drug Development Research Laboratories, Pharma Research and Development Division, Hoechst Japan Limi
-
KAWAMURA Nobuyuki
Drug Safety Evaluation, Lead Optimization, Drug Innovation & Approval Division, Aventis Pharma Ltd.
-
Tsutsumi S.
日本製薬工業協会
著作論文
- P-83 Collaborative work for evaluation of toxicity on male reproductive organs by repeated dose studies in rats : Effects of daily subcutaneous administration of reserpine on spermatogenesis for 2 and 4 weeks(Proceedings of the 27th Annual Meeting)
- COLLABORATIVE WORK TO EVALUATE TOXICITY ON MALE REPRODUCTIVE ORGANS BY REPEATED DOSE STUDIES IN RATS : 8)EFFECTS OF DAILY SUBCUTANEOUS ADMINISTRATION OF RESERPINE ON SPERMATOGENESIS FOR 2 AND 4 WEEKS